Kevin Caliendo
Stock Analyst at UBS
(4.57)
# 184
Out of 4,842 analysts
182
Total ratings
71.62%
Success rate
12.33%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFST LifeStance Health Group | Upgrades: Buy | $8.5 | $5.91 | +43.82% | 4 | May 27, 2025 | |
| ZIMV ZimVie | Maintains: Neutral | $16 → $10 | $8.93 | +12.04% | 1 | May 15, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $6 → $5.25 | $3.81 | +37.98% | 4 | May 13, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $27 → $25 | $16.33 | +53.09% | 10 | May 9, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $15 | $7.37 | +103.53% | 3 | May 9, 2025 | |
| AMWL American Well | Maintains: Neutral | $12 → $9 | $6.91 | +30.25% | 3 | May 8, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $21 → $18 | $18.46 | -2.49% | 3 | May 5, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $16 → $17 | $14.90 | +14.13% | 7 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $160 → $170 | $153.99 | +10.40% | 17 | May 2, 2025 | |
| CVS CVS Health | Maintains: Neutral | $67 → $71 | $62.78 | +13.09% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $708 → $805 | $712.86 | +12.93% | 14 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $290.69 | +15.24% | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $215 | $183.05 | +17.45% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $83 → $80 | $71.95 | +11.20% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $13 | $6.50 | +100.00% | 5 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $330 → $305 | $303.87 | +0.37% | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $312.05 | +24.98% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $166 → $170 | $172.00 | -1.16% | 13 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $293 → $286 | $246.75 | +15.91% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $11.24 | -10.99% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $680 → $650 | $298.17 | +118.00% | 11 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $230.08 | +8.66% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $56.52 | +39.77% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $22.97 | +13.19% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $380.53 | +51.11% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $153.58 | +17.20% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $6.98 | +931.52% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $17.53 | -37.25% | 4 | May 4, 2021 |
LifeStance Health Group
May 27, 2025
Upgrades: Buy
Price Target: $8.5
Current: $5.91
Upside: +43.82%
ZimVie
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $8.93
Upside: +12.04%
GoodRx Holdings
May 13, 2025
Maintains: Neutral
Price Target: $6 → $5.25
Current: $3.81
Upside: +37.98%
DENTSPLY SIRONA
May 9, 2025
Maintains: Buy
Price Target: $27 → $25
Current: $16.33
Upside: +53.09%
Evolent Health
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $7.37
Upside: +103.53%
American Well
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.91
Upside: +30.25%
Envista Holdings
May 5, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $18.46
Upside: -2.49%
Alignment Healthcare
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $14.90
Upside: +14.13%
Cardinal Health
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $153.99
Upside: +10.40%
CVS Health
May 2, 2025
Maintains: Neutral
Price Target: $67 → $71
Current: $62.78
Upside: +13.09%
Apr 29, 2025
Maintains: Buy
Price Target: $708 → $805
Current: $712.86
Upside: +12.93%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $290.69
Upside: +15.24%
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $183.05
Upside: +17.45%
Feb 26, 2025
Maintains: Neutral
Price Target: $83 → $80
Current: $71.95
Upside: +11.20%
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $6.50
Upside: +100.00%
Feb 7, 2025
Maintains: Neutral
Price Target: $330 → $305
Current: $303.87
Upside: +0.37%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $312.05
Upside: +24.98%
Feb 3, 2025
Maintains: Neutral
Price Target: $166 → $170
Current: $172.00
Upside: -1.16%
Jan 28, 2025
Maintains: Buy
Price Target: $293 → $286
Current: $246.75
Upside: +15.91%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $11.24
Upside: -10.99%
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $298.17
Upside: +118.00%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $230.08
Upside: +8.66%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $56.52
Upside: +39.77%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $22.97
Upside: +13.19%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $380.53
Upside: +51.11%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $153.58
Upside: +17.20%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $6.98
Upside: +931.52%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $17.53
Upside: -37.25%